img

Global Dipeptidyl Peptidase-4 Inhibitors Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dipeptidyl Peptidase-4 Inhibitors Market Research Report 2024

A dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor) is a type of medication used to treat type 2 diabetes. DPP-4 is an enzyme that breaks down the hormone incretin, which stimulates insulin release from pancreatic beta cells. By inhibiting DPP-4, DPP-4 inhibitors increase incretin levels and improve glucose control in patients with type 2 diabetes. Examples of DPP-4 inhibitors include sitagliptin, saxagliptin, linagliptin, and alogliptin. These drugs are taken orally, usually once daily, and are generally well tolerated. They can be used alone or in combination with other diabetes medications, such as metformin or insulin.
According to Mr Accuracy reports’s new survey, global Dipeptidyl Peptidase-4 Inhibitors market is projected to reach US$ 18820 million in 2034, increasing from US$ 12800 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dipeptidyl Peptidase-4 Inhibitors market research.
Key manufacturers engaged in the Dipeptidyl Peptidase-4 Inhibitors industry include Merck, Boehringer Ingelheim, AstraZeneca, Takeda Pharmaceutical, Novartis, Jiangsu Hansoh Pharmaceutical, Qilu Pharmaceutical, Beijing Tide Pharmaceutical and CTTQ, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Dipeptidyl Peptidase-4 Inhibitors were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Dipeptidyl Peptidase-4 Inhibitors market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dipeptidyl Peptidase-4 Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Boehringer Ingelheim
AstraZeneca
Takeda Pharmaceutical
Novartis
Jiangsu Hansoh Pharmaceutical
Qilu Pharmaceutical
Beijing Tide Pharmaceutical
CTTQ
Jiangsu Deyuan Pharmaceutical
Jiujiang Zhongtian Pharmaceutical
Yabao Pharmaceutical
Segment by Type
Sitagliptin
Saxagliptin
Vildagliptin
Linagliptin
Alogliptin
Other

Segment by Application


Hospital
Clinic
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dipeptidyl Peptidase-4 Inhibitors report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Dipeptidyl Peptidase-4 Inhibitors Market Overview
1.1 Product Overview and Scope of Dipeptidyl Peptidase-4 Inhibitors
1.2 Dipeptidyl Peptidase-4 Inhibitors Segment by Type
1.2.1 Global Dipeptidyl Peptidase-4 Inhibitors Market Value Comparison by Type (2024-2034)
1.2.2 Sitagliptin
1.2.3 Saxagliptin
1.2.4 Vildagliptin
1.2.5 Linagliptin
1.2.6 Alogliptin
1.2.7 Other
1.3 Dipeptidyl Peptidase-4 Inhibitors Segment by Application
1.3.1 Global Dipeptidyl Peptidase-4 Inhibitors Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Dipeptidyl Peptidase-4 Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Dipeptidyl Peptidase-4 Inhibitors Revenue 2024-2034
1.4.2 Global Dipeptidyl Peptidase-4 Inhibitors Sales 2024-2034
1.4.3 Global Dipeptidyl Peptidase-4 Inhibitors Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Dipeptidyl Peptidase-4 Inhibitors Market Competition by Manufacturers
2.1 Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Manufacturers (2024-2024)
2.2 Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Manufacturers (2024-2024)
2.4 Global Dipeptidyl Peptidase-4 Inhibitors Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Dipeptidyl Peptidase-4 Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dipeptidyl Peptidase-4 Inhibitors, Product Type & Application
2.7 Dipeptidyl Peptidase-4 Inhibitors Market Competitive Situation and Trends
2.7.1 Dipeptidyl Peptidase-4 Inhibitors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dipeptidyl Peptidase-4 Inhibitors Players Market Share by Revenue
2.7.3 Global Dipeptidyl Peptidase-4 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dipeptidyl Peptidase-4 Inhibitors Retrospective Market Scenario by Region
3.1 Global Dipeptidyl Peptidase-4 Inhibitors Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Dipeptidyl Peptidase-4 Inhibitors Global Dipeptidyl Peptidase-4 Inhibitors Sales by Region: 2024-2034
3.2.1 Global Dipeptidyl Peptidase-4 Inhibitors Sales by Region: 2024-2024
3.2.2 Global Dipeptidyl Peptidase-4 Inhibitors Sales by Region: 2024-2034
3.3 Global Dipeptidyl Peptidase-4 Inhibitors Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Region: 2024-2034
3.3.1 Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Region: 2024-2024
3.3.2 Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Region: 2024-2034
3.4 North America Dipeptidyl Peptidase-4 Inhibitors Market Facts & Figures by Country
3.4.1 North America Dipeptidyl Peptidase-4 Inhibitors Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2034)
3.4.3 North America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dipeptidyl Peptidase-4 Inhibitors Market Facts & Figures by Country
3.5.1 Europe Dipeptidyl Peptidase-4 Inhibitors Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2034)
3.5.3 Europe Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Market Facts & Figures by Country
3.6.1 Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2034)
3.6.3 Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dipeptidyl Peptidase-4 Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Dipeptidyl Peptidase-4 Inhibitors Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2034)
3.7.3 Latin America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2034)
3.8.3 Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dipeptidyl Peptidase-4 Inhibitors Sales by Type (2024-2034)
4.1.1 Global Dipeptidyl Peptidase-4 Inhibitors Sales by Type (2024-2024)
4.1.2 Global Dipeptidyl Peptidase-4 Inhibitors Sales by Type (2024-2034)
4.1.3 Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type (2024-2034)
4.2 Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Type (2024-2034)
4.2.1 Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Type (2024-2024)
4.2.2 Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Type (2024-2034)
4.2.3 Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Type (2024-2034)
4.3 Global Dipeptidyl Peptidase-4 Inhibitors Price by Type (2024-2034)
5 Segment by Application
5.1 Global Dipeptidyl Peptidase-4 Inhibitors Sales by Application (2024-2034)
5.1.1 Global Dipeptidyl Peptidase-4 Inhibitors Sales by Application (2024-2024)
5.1.2 Global Dipeptidyl Peptidase-4 Inhibitors Sales by Application (2024-2034)
5.1.3 Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Application (2024-2034)
5.2 Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Application (2024-2034)
5.2.1 Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Application (2024-2024)
5.2.2 Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Application (2024-2034)
5.2.3 Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Application (2024-2034)
5.3 Global Dipeptidyl Peptidase-4 Inhibitors Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Merck Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.3.4 AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Takeda Pharmaceutical
6.4.1 Takeda Pharmaceutical Corporation Information
6.4.2 Takeda Pharmaceutical Description and Business Overview
6.4.3 Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.4.5 Takeda Pharmaceutical Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Novartis Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Jiangsu Hansoh Pharmaceutical
6.6.1 Jiangsu Hansoh Pharmaceutical Corporation Information
6.6.2 Jiangsu Hansoh Pharmaceutical Description and Business Overview
6.6.3 Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.6.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
6.7 Qilu Pharmaceutical
6.6.1 Qilu Pharmaceutical Corporation Information
6.6.2 Qilu Pharmaceutical Description and Business Overview
6.6.3 Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.7.5 Qilu Pharmaceutical Recent Developments/Updates
6.8 Beijing Tide Pharmaceutical
6.8.1 Beijing Tide Pharmaceutical Corporation Information
6.8.2 Beijing Tide Pharmaceutical Description and Business Overview
6.8.3 Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.8.5 Beijing Tide Pharmaceutical Recent Developments/Updates
6.9 CTTQ
6.9.1 CTTQ Corporation Information
6.9.2 CTTQ Description and Business Overview
6.9.3 CTTQ Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.9.4 CTTQ Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.9.5 CTTQ Recent Developments/Updates
6.10 Jiangsu Deyuan Pharmaceutical
6.10.1 Jiangsu Deyuan Pharmaceutical Corporation Information
6.10.2 Jiangsu Deyuan Pharmaceutical Description and Business Overview
6.10.3 Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.10.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
6.11 Jiujiang Zhongtian Pharmaceutical
6.11.1 Jiujiang Zhongtian Pharmaceutical Corporation Information
6.11.2 Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Description and Business Overview
6.11.3 Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.11.5 Jiujiang Zhongtian Pharmaceutical Recent Developments/Updates
6.12 Yabao Pharmaceutical
6.12.1 Yabao Pharmaceutical Corporation Information
6.12.2 Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Description and Business Overview
6.12.3 Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolio
6.12.5 Yabao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dipeptidyl Peptidase-4 Inhibitors Industry Chain Analysis
7.2 Dipeptidyl Peptidase-4 Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dipeptidyl Peptidase-4 Inhibitors Production Mode & Process
7.4 Dipeptidyl Peptidase-4 Inhibitors Sales and Marketing
7.4.1 Dipeptidyl Peptidase-4 Inhibitors Sales Channels
7.4.2 Dipeptidyl Peptidase-4 Inhibitors Distributors
7.5 Dipeptidyl Peptidase-4 Inhibitors Customers
8 Dipeptidyl Peptidase-4 Inhibitors Market Dynamics
8.1 Dipeptidyl Peptidase-4 Inhibitors Industry Trends
8.2 Dipeptidyl Peptidase-4 Inhibitors Market Drivers
8.3 Dipeptidyl Peptidase-4 Inhibitors Market Challenges
8.4 Dipeptidyl Peptidase-4 Inhibitors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Dipeptidyl Peptidase-4 Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Dipeptidyl Peptidase-4 Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Dipeptidyl Peptidase-4 Inhibitors Market Competitive Situation by Manufacturers in 2022
Table 4. Global Dipeptidyl Peptidase-4 Inhibitors Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Dipeptidyl Peptidase-4 Inhibitors Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Dipeptidyl Peptidase-4 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Dipeptidyl Peptidase-4 Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Dipeptidyl Peptidase-4 Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dipeptidyl Peptidase-4 Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Dipeptidyl Peptidase-4 Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dipeptidyl Peptidase-4 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase-4 Inhibitors as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dipeptidyl Peptidase-4 Inhibitors Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Dipeptidyl Peptidase-4 Inhibitors Sales by Region (2024-2024) & (K Units)
Table 18. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Region (2024-2024)
Table 19. Global Dipeptidyl Peptidase-4 Inhibitors Sales by Region (2024-2034) & (K Units)
Table 20. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Region (2024-2034)
Table 21. Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Region (2024-2024)
Table 23. Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Region (2024-2034)
Table 25. North America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2024) & (K Units)
Table 27. North America Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2034) & (K Units)
Table 28. North America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2024) & (K Units)
Table 32. Europe Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2034) & (K Units)
Table 33. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Dipeptidyl Peptidase-4 Inhibitors Sales (K Units) by Type (2024-2024)
Table 51. Global Dipeptidyl Peptidase-4 Inhibitors Sales (K Units) by Type (2024-2034)
Table 52. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type (2024-2024)
Table 53. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type (2024-2034)
Table 54. Global Dipeptidyl Peptidase-4 Inhibitors Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Dipeptidyl Peptidase-4 Inhibitors Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Type (2024-2024)
Table 57. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Type (2024-2034)
Table 58. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Type (2024-2024)
Table 59. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Type (2024-2034)
Table 60. Global Dipeptidyl Peptidase-4 Inhibitors Sales (K Units) by Application (2024-2024)
Table 61. Global Dipeptidyl Peptidase-4 Inhibitors Sales (K Units) by Application (2024-2034)
Table 62. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Application (2024-2024)
Table 63. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Application (2024-2034)
Table 64. Global Dipeptidyl Peptidase-4 Inhibitors Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Dipeptidyl Peptidase-4 Inhibitors Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Application (2024-2024)
Table 67. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Application (2024-2034)
Table 68. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Application (2024-2024)
Table 69. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Merck Dipeptidyl Peptidase-4 Inhibitors Product
Table 74. Merck Recent Developments/Updates
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Takeda Pharmaceutical Corporation Information
Table 86. Takeda Pharmaceutical Description and Business Overview
Table 87. Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 89. Takeda Pharmaceutical Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Novartis Dipeptidyl Peptidase-4 Inhibitors Product
Table 94. Novartis Recent Developments/Updates
Table 95. Jiangsu Hansoh Pharmaceutical Corporation Information
Table 96. Jiangsu Hansoh Pharmaceutical Description and Business Overview
Table 97. Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 99. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
Table 100. Qilu Pharmaceutical Corporation Information
Table 101. Qilu Pharmaceutical Description and Business Overview
Table 102. Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 104. Qilu Pharmaceutical Recent Developments/Updates
Table 105. Beijing Tide Pharmaceutical Corporation Information
Table 106. Beijing Tide Pharmaceutical Description and Business Overview
Table 107. Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 109. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 110. CTTQ Corporation Information
Table 111. CTTQ Description and Business Overview
Table 112. CTTQ Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. CTTQ Dipeptidyl Peptidase-4 Inhibitors Product
Table 114. CTTQ Recent Developments/Updates
Table 115. Jiangsu Deyuan Pharmaceutical Corporation Information
Table 116. Jiangsu Deyuan Pharmaceutical Description and Business Overview
Table 117. Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 119. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
Table 120. Jiujiang Zhongtian Pharmaceutical Corporation Information
Table 121. Jiujiang Zhongtian Pharmaceutical Description and Business Overview
Table 122. Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 124. Jiujiang Zhongtian Pharmaceutical Recent Developments/Updates
Table 125. Yabao Pharmaceutical Corporation Information
Table 126. Yabao Pharmaceutical Description and Business Overview
Table 127. Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 129. Yabao Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Dipeptidyl Peptidase-4 Inhibitors Distributors List
Table 133. Dipeptidyl Peptidase-4 Inhibitors Customers List
Table 134. Dipeptidyl Peptidase-4 Inhibitors Market Trends
Table 135. Dipeptidyl Peptidase-4 Inhibitors Market Drivers
Table 136. Dipeptidyl Peptidase-4 Inhibitors Market Challenges
Table 137. Dipeptidyl Peptidase-4 Inhibitors Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dipeptidyl Peptidase-4 Inhibitors
Figure 2. Global Dipeptidyl Peptidase-4 Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Dipeptidyl Peptidase-4 Inhibitors Market Share by Type in 2022 & 2034
Figure 4. Sitagliptin Product Picture
Figure 5. Saxagliptin Product Picture
Figure 6. Vildagliptin Product Picture
Figure 7. Linagliptin Product Picture
Figure 8. Alogliptin Product Picture
Figure 9. Other Product Picture
Figure 10. Global Dipeptidyl Peptidase-4 Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Dipeptidyl Peptidase-4 Inhibitors Market Share by Application in 2022 & 2034
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Other
Figure 15. Global Dipeptidyl Peptidase-4 Inhibitors Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 16. Global Dipeptidyl Peptidase-4 Inhibitors Market Size (2024-2034) & (US$ Million)
Figure 17. Global Dipeptidyl Peptidase-4 Inhibitors Sales (2024-2034) & (K Units)
Figure 18. Global Dipeptidyl Peptidase-4 Inhibitors Average Price (US$/Unit) & (2024-2034)
Figure 19. Dipeptidyl Peptidase-4 Inhibitors Report Years Considered
Figure 20. Dipeptidyl Peptidase-4 Inhibitors Sales Share by Manufacturers in 2022
Figure 21. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Dipeptidyl Peptidase-4 Inhibitors Players: Market Share by Revenue in 2022
Figure 23. Dipeptidyl Peptidase-4 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 24. Global Dipeptidyl Peptidase-4 Inhibitors Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 25. North America Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country (2024-2034)
Figure 26. North America Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country (2024-2034)
Figure 27. United States Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Canada Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country (2024-2034)
Figure 30. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country (2024-2034)
Figure 31. Germany Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. France Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. U.K. Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Italy Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Russia Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Region (2024-2034)
Figure 37. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Region (2024-2034)
Figure 38. China Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Japan Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. South Korea Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. India Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Australia Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. China Taiwan Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Southeast Asia Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Latin America Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country (2024-2034)
Figure 46. Latin America Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country (2024-2034)
Figure 47. Mexico Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Brazil Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Argentina Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country (2024-2034)
Figure 51. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country (2024-2034)
Figure 52. Turkey Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. UAE Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Dipeptidyl Peptidase-4 Inhibitors by Type (2024-2034)
Figure 56. Global Revenue Market Share of Dipeptidyl Peptidase-4 Inhibitors by Type (2024-2034)
Figure 57. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Type (2024-2034)
Figure 58. Global Sales Market Share of Dipeptidyl Peptidase-4 Inhibitors by Application (2024-2034)
Figure 59. Global Revenue Market Share of Dipeptidyl Peptidase-4 Inhibitors by Application (2024-2034)
Figure 60. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Application (2024-2034)
Figure 61. Dipeptidyl Peptidase-4 Inhibitors Value Chain
Figure 62. Dipeptidyl Peptidase-4 Inhibitors Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries